Mikhail Papisov
Mikhail Papisov
Massachusetts General Hospital, Harvard Medical School and Shriners Hospitals for Children
Adresse e-mail validée de helix.mgh.harvard.edu
Citée par
Citée par
Monocrystalline iron oxide nanocompounds (MION): physicochemical properties
T Shen, R Weissleder, M Papisov, A Bogdanov Jr, TJ Brady
Magnetic Resonance in Medicine 29 (5), 599-604, 1993
Poly (ethylene glycol) on the liposome surface: on the mechanism of polymer-coated liposome longevity
VP Torchilin, VG Omelyanenko, MI Papisov, AA Bogdanov Jr, ...
Biochimica et Biophysica Acta (BBA)-Biomembranes 1195 (1), 11-20, 1994
Long-circulating iron oxides for MR imaging
R Weissleder, A Bogdanov, EA Neuwelt, M Papisov
Advanced Drug Delivery Reviews 16 (2-3), 321-334, 1995
A new macromolecule as a contrast agent for MR angiography: preparation, properties, and animal studies.
AA Bogdanov Jr, R Weissleder, HW Frank, AV Bogdanova, N Nossif, ...
Radiology 187 (3), 701-706, 1993
Why do polyethylene glycol-coated liposomes circulate so long?: Molecular mechanism of liposome steric protection with polyethylene glycol: Role of polymer chain flexibility
VP Torchilinl, MI Papisov
Journal of liposome research 4 (1), 725-739, 1994
MR lymphography: study of a high-efficiency lymphotrophic agent.
R Weissleder, JF Heautot, BK Schaffer, N Nossiff, MI Papisov, ...
Radiology 191 (1), 225-230, 1994
Colloidal magnetic resonance contrast agents: effect of particle surface on biodistribution
MI Papisov, A Bogdanov Jr, B Schaffer, N Nossiff, T Shen, R Weissleder, ...
Journal of Magnetism and Magnetic Materials 122 (1-3), 383-386, 1993
Theoretical considerations of RES-avoiding liposomes: molecular mechanics and chemistry of liposome interactions
MI Papisov
Advanced drug delivery reviews 32 (1-2), 119-138, 1998
CNS penetration of intrathecal-lumbar idursulfase in the monkey, dog and mouse: implications for neurological outcomes of lysosomal storage disorder
P Calias, M Papisov, J Pan, N Savioli, V Belov, Y Huang, J Lotterhand, ...
PloS one 7 (1), e30341, 2012
Pharmaceutical iron oxides for MR imaging
R Weissleder, M Papisov
Rev Magn Reson Med 4, 1-20, 1992
In vivo degradation of silicones
L Garrido, B Pfleiderer, M Papisov, JL Ackerman
Magnetic resonance in medicine 29 (6), 839-843, 1993
Drug targeting in magnetic resonance imaging.
R Weissleder, A Bogdanov, M Papisov
Magnetic Resonance Quarterly 8 (1), 55-63, 1992
MR Lymphography with a Lymphotropic T1‐Type MR Contrast Agent: Gd‐DTPA‐PGM
L Harika, R Weissleder, K Poss, C Zimmer, MI Papisov, TJ Brady
Magnetic resonance in medicine 33 (1), 88-92, 1995
MION-ASF: biokinetics of an MR receptor agent
BK Schaffer, C Linker, M Papisov, E Tsai, N Nossiff, T Shibata, ...
Magnetic resonance imaging 11 (3), 411-417, 1993
Targeted delivery of diagnostic agents by surface-modified liposomes
VP Torchilin, VS Trubetskoy, AM Milshteyn, J Canillo, GL Wolf, MI Papisov, ...
Advances in Drug Delivery Systems, 6, 45-58, 1994
Physiology of the intrathecal bolus: the leptomeningeal route for macromolecule and particle delivery to CNS
MI Papisov, VV Belov, KS Gannon
Molecular pharmaceutics 10 (5), 1522-1532, 2013
System of drug delivery to the lymphatic tissues
MI Papisov, TJ Brady
US Patent 5,582,172, 1996
Macromolecular intravenous contrast agent for MR lymphography: characterization and efficacy studies.
L Harika, R Weissleder, K Poss, MI Papisov
Radiology 198 (2), 365-370, 1996
Conjugates comprising a biodegradable polymer and uses therefor
DR Elmaleh, SC Robson, ML Papisov
US Patent 7,785,618, 2010
Biodegradable polyketal polymers and methods for their formation and use
MI Papisov
US Patent 7,838,619, 2010
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20